Summary & Overview
Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC: Inpatient Reimbursement Overview
DRG 843 includes admissions for other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with a Major Complication or Comorbidity, reflecting higher clinical complexity. This classification matters for inpatient reimbursement because it increases the payment weight to account for greater resource use and severity under Medicare rules.
DRG 843 Overview
DRG 843 covers hospital admissions for other myeloproliferative disorders or poorly differentiated neoplastic diagnoses when a Major Complication or Comorbidity is present. These cases typically involve complex hematologic or oncologic workups, intensive inpatient management, and potential complications that increase resource use. The Diagnosis-Related Group influences Medicare payment by grouping clinical complexity and resource consumption into a single reimbursement weight. Accurate documentation of diagnoses and Major Complication or Comorbidity is central to correct inpatient payment under Medicare.